SHIV/HIV Env-antibody coevolution as a molecular guide to V3 glycan targeted vaccine design
Research Grant
Awarded By
University of Pennsylvania
Start Date
July 1, 2024
End Date
March 31, 2027
Awarded By
University of Pennsylvania
Start Date
July 1, 2024
End Date
March 31, 2027